Source: Documenta Ophthalmologica. Unidade: FMRP
Subjects: ANTICORPOS MONOCLONAIS, ELETRORRETINOGRAFIA, DIABETES MELLITUS, RETINA (PATOLOGIA)
ABNT
MESSIAS, André Márcio Vieira et al. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Documenta Ophthalmologica, v. 124, n. 3, p. 225-236, 2012Tradução . . Disponível em: https://doi.org/10.1007/s10633-012-9322-5. Acesso em: 18 nov. 2024.APA
Messias, A. M. V., Ramos Filho, J. A., Messias, K., Almeida, F. P. P. de, Costa, R. A., Scott, I. U., et al. (2012). Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Documenta Ophthalmologica, 124( 3), 225-236. doi:10.1007/s10633-012-9322-5NLM
Messias AMV, Ramos Filho JA, Messias K, Almeida FPP de, Costa RA, Scott IU, Gekeler F, Jorge R. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy [Internet]. Documenta Ophthalmologica. 2012 ; 124( 3): 225-236.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s10633-012-9322-5Vancouver
Messias AMV, Ramos Filho JA, Messias K, Almeida FPP de, Costa RA, Scott IU, Gekeler F, Jorge R. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy [Internet]. Documenta Ophthalmologica. 2012 ; 124( 3): 225-236.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s10633-012-9322-5